Figure 1.
Treatment approach for patients with high-risk MCL. alloSCT, allogeneic stem cell transplant; BCL2i, B-cell lymphoma 2 inhibitor; CD20Ab, CD20 monoclonal antibody.

Treatment approach for patients with high-risk MCL. alloSCT, allogeneic stem cell transplant; BCL2i, B-cell lymphoma 2 inhibitor; CD20Ab, CD20 monoclonal antibody.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal